Viewing Study NCT04708418

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:48 AM
Ignite Modification Date: 2026-06-10 @ 10:19 AM
Study NCT ID: NCT04708418
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-26
First Post: 2021-01-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Clinical Stage III Cutaneous Melanoma AJCC v8 View
None Melanoma of Unknown Primary View
None Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 View
None Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 View
None Pathologic Stage IIID Cutaneous Melanoma AJCC v8 View
None Recurrent Cutaneous Melanoma View
Keywords: